Remedi is born from the merger of Regenera Activa and Rigenera HBW, biotech companies specialized in regenerative medicine

Remedi诞生于Regenera Activa和Rigenera HBW的合并，这两家生物技术公司专门从事再生医学

The company works with the patented Rigenera® technology, an innovative noninvasive treatment based on autologous biological components containing progenitor cells

该公司使用获得专利的Rigenera®技术，这是一种基于含有祖细胞的自体生物成分的创新无创治疗方法

With one session, results are visible in two weeks and hold for more than three years

通过一次会议，结果将在两周内显现，并持续三年以上

The company seeks new investors to establish its sales network in the United States to grow and double its revenue by 2026.

该公司寻求新的投资者在美国建立销售网络，以在2026年前实现收入增长并翻一番。

BARCELONA, Spain, July 17, 2024 /PRNewswire/ -- According to WHO, 528 million people suffer from joint pain. Age, obesity, and sports can lead to cartilage wear and osteoarthritis. While surgery or implants are common treatments, with the USA accountable for about 30% of global joint replacements, regenerative medicine is emerging as more effective and less invasive..

西班牙巴塞罗那，2024年7月17日，据世界卫生组织统计，有5.28亿人患有关节疼痛。年龄、肥胖和运动会导致软骨磨损和骨关节炎。虽然手术或植入物是常见的治疗方法，但美国约占全球关节置换术的30%，再生医学正在变得更有效，侵入性更小。。

Continue Reading

继续阅读

(L-R) Dr. José Miguel Casanova, Alexandre Andreu, Dr. Antonio Graziano. Remedi founders.

（左-右）JoséMiguel Casanova博士，Alexandre Andreu，Antonio Graziano博士。Remedi创始人。

In this field, the biotech company Remedi is born, resulting from the merger of the Spanish Regenera Activa Worldwide and the Italian Rigenera HBW. The company works with the patented Rigenera® technology, a unique and innovative minimally invasive treatment based on patient's own cells injected through micrografts.

在这一领域，西班牙Regenera Activa Worldwide和意大利Rigenera HBW合并后，生物技术公司Remedi应运而生。该公司使用获得专利的Rigenera®技术，这是一种独特而创新的微创治疗方法，基于通过显微注射的患者自身细胞。

As a result, Remedi is now present in 70 countries and has a turnover of over 13 million euros..

因此，Remedi目前已遍布70个国家，营业额超过1300万欧元。。

'Our goal is to continue growing and double our turnover in two years. To achieve this, the U.S. is key market where we are not yet present and where we are raising capital to set up our own distribution network' explains Alexandre Andreu, Remedi's CEO.

“我们的目标是在两年内继续增长，营业额翻一番。为了实现这一目标，美国是我们尚未涉足的关键市场，我们正在筹集资金建立自己的分销网络”，雷迪首席执行官亚历山大安德烈（AlexandreAndreu）解释道。

Today, Rigenera® technology is used by more than 10,000 doctors worldwide, and over 450,000 treatments have been performed with it. Simultaneously, the company has also started its distribution in China, a market expected to help reach 22.5 million euros in turnover in 2025.A Pioneering TherapyRigenera® technology represents a radical change compared to current treatments, as it halts osteoarthritis and joint degeneration without resorting to prosthetics, relieving pain and improving the patients' life's quality.The procedure uses a combination of autologous (from the same donor) and homologous (from the same tissue), effectively treating the affected area with the patient's own specific cells and tissue.

如今，全世界有10000多名医生使用Rigenera®技术，已经进行了45万多次治疗。同时，该公司还开始在中国销售，预计2025年该市场的营业额将达到2250万欧元。与目前的治疗方法相比，开创性的TherapyRigenera®技术代表着一个根本性的变化，因为它可以停止骨关节炎和关节退行性变，而无需使用假肢，缓解疼痛并提高患者的生活质量。该程序使用自体（来自同一供体）和同源（来自同一组织）的组合，用患者自身的特定细胞和组织有效治疗受影响的区域。

This solution is unique because it contains, among other elements, progenitor cells, unlike any other alternative. This eliminates the rejection risk and leverages the body's natural healing capabilities.It is the only treatment available that combines different biological components of specific tissue that have not been manipulated, maximizing healing power.

这种解决方案是独特的，因为它与其他任何替代方案不同，其中包含祖细胞。这消除了拒绝风险，并利用了身体的自然愈合能力。这是唯一一种结合未经操作的特定组织的不同生物成分的治疗方法，最大限度地提高了愈合能力。

This makes it extremely effective, safe and simple, providing long-lasting results in a single session.Also, Rigenera® can stimulate the regeneration process in tissues, allowing treatments such as hair regeneration, stretch mark treatment, and complex wound healing. For this purpose, Remedi distributes the Rigenera® Emergency Kit for military and civilian emergencies in conflict zones and has been selected for NATO's Rawints Project (Rapid Wound Healing).More information: Media contactATREVIA - Xavier Torrent Maestro; Consultantxtorrent@atrevia.com +34 619 174 366Photo - https://mma.prnewswire.com/media/2463478/Remedi.jpgSOURCE Remedi.

这使得它非常有效，安全和简单，在一次会议中提供持久的结果。。为此，Remedi为冲突地区的军事和民用紧急情况分发了Rigenera®应急工具包，并被选为北约的Rawints项目（快速伤口愈合）。更多信息：媒体联系人Revia-Xavier Torrent Maestro；（笑声）Consultantxtorrent@atrevia.com+34 619 174 366照片-https://mma.prnewswire.com/media/2463478/Remedi.jpgSOURCE补救。